Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases

Tryptophan is metabolized primarily via the kynurenine pathway (KP), which involves several enzymes, including indoleamine 2,3-dioxygenase, tryptophan 2,3 dioxygenase (TDO), kynurenine aminotransferases (KATs), kynurenine monooxygenase (KMO) etc. The majority of metabolites are neuroactive: some of...

Full description

Saved in:
Bibliographic Details
Main Authors: Boros Fanni Annamária
Bohár Zsuzsanna
Vécsei László
Format: Article
Published: 2018
Series:MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 776
doi:10.1016/j.mrrev.2018.03.001

mtmt:3365227
Online Access:http://publicatio.bibl.u-szeged.hu/14306
LEADER 03176nab a2200253 i 4500
001 publ14306
005 20190402113154.0
008 190116s2018 hu o 0|| zxx d
022 |a 1383-5742 
024 7 |a 10.1016/j.mrrev.2018.03.001  |2 doi 
024 7 |a 3365227  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Boros Fanni Annamária 
245 1 0 |a Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases  |h [elektronikus dokumentum] /  |c  Boros Fanni Annamária 
260 |c 2018 
300 |a 32-45 
490 0 |a MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH  |v 776 
520 3 |a Tryptophan is metabolized primarily via the kynurenine pathway (KP), which involves several enzymes, including indoleamine 2,3-dioxygenase, tryptophan 2,3 dioxygenase (TDO), kynurenine aminotransferases (KATs), kynurenine monooxygenase (KMO) etc. The majority of metabolites are neuroactive: some of them, such as kynurenic acid, show neuroprotective effects, while others contribute to free radical production, leading to neurodegeneration. Imbalance of the pathway is assumed to contribute to the development of several neurodegenerative diseases, psychiatric disorders, migraine and multiple sclerosis. Our aim was to summarize published data on genetic alterations of enzymes involved in the KP leading to disturbances of the pathway that can be related to different diseases. To achieve this, a PubMed literature search was performed for publications on genetic alterations of the KP enzymes upto April 2017. Several genetic alterations of the KP have been identified and have been proposed to be associated with diseases. Here we must emphasize that despite the large number of recognized genetic alterations, the number of firmly established causal relations with specific diseases is still small. The realization of this by those interested in the field is very important and finding such connections should be a major focus of related research. Polymorphisms of the genes encoding the enzymes of the KP have been associated with autism, multiple sclerosis and schizophrenia, and were shown to affect the immune response of patients with bacterial meningitis, just to mention a few. To our knowledge, this is the first comprehensive review of the genetic alterations of the KP enzymes. We believe that the identification of genetic alterations underlying diseases has great value regarding both treatment and diagnostics in precision medicine, as this work can promote the understanding of pathological mechanisms, and might facilitate medicinal chemistry approaches to substitute missing components or correct the disturbed metabolite balance of KP. © 2018 Elsevier B.V. 
700 0 1 |a Bohár Zsuzsanna  |e aut 
700 0 1 |a Vécsei László  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/14306/8/pagination_MUTREV_8235_repozi14306.pdf  |z Dokumentum-elérés  
856 4 0 |u http://publicatio.bibl.u-szeged.hu/14306/1/BoroFanni.Geneticalterations..pdf  |z Dokumentum-elérés  
856 4 0 |u http://publicatio.bibl.u-szeged.hu/14306/10/mutation_research_editoral.pdf  |z Dokumentum-elérés